# Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

> **NCT00376038** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 13 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK189075 oral tablets
- **DRUG:** metformin tablets

## Key facts

- **NCT ID:** NCT00376038
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376038, "Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00376038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*